Electroconvulsive therapy improves severe pain associated with fibromyalgia.
The pathophysiology of fibromyalgia remains unknown. Several reports have recently suggested the novel concept that fibromyalgia is due to the central nervous system becoming hyper-responsive to a peripheral stimulus. The effect of electroconvulsive therapy (ECT) as pain remedication in cases of fibromyalgia without major depressive disorder was studied in a prospective trial lasting three months. All of the patients taking part in the study fulfilled the American College of Rheumatology diagnostic criteria for fibromyalgia. Technetium-99m ethyl cysteinate dimer single photon emission computed tomography was used to assess regional cerebral blood flow (rCBF) before and after a course of ECT. Pain assessment in the patients was undertaken by use of the visual analog scale (VAS) and by evaluation of tender points (TPs). Beck's depression inventory (BDI) was further used to assess depressive mood change in the patients. Our study clearly demonstrated that pain was significantly less severe after ECT, as indicated by the VAS scale for pain and the evaluation of TPs. A further notable observation was that thalamic blood flow was also improved. We conclude that a course of ECT produced notable improvements in both intractable severe pain associated with fibromyalgia and also in terms of thalamic blood flow.
Usui
Chie
C
Department of Psychiatry, Juntendo University School of Medicine, Tokyo, Japan Department of Neuropsychiatry, Faculty of Medicine, Tokyo University, Tokyo, Japan Department of Radiology, Jikei University School of Medicine, Tokyo, Japan Department of Anesthesiology, Juntendo University School of Medicine, Tokyo, Japan Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
Doi
Nagafumi
N
Nishioka
Makiko
M
Komatsu
Hiroyuki
H
Yamamoto
Ryoko
R
Ohkubo
Taku
T
Ishizuka
Takuya
T
Shibata
Nobuto
N
Hatta
Kotaro
K
Miyazaki
Haruhiro
H
Nishioka
Kusuki
K
Arai
Heii
H
D000328:Adult; D000368:Aged; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology; D003863:Depression / Q000209:etiology / Q000523:psychology / Q000628:therapy; D004565:Electroconvulsive Therapy / Q000379:methods*; D005260:Female; D005356:Fibromyalgia / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009434:Neural Pathways / Q000000981:diagnostic imaging / Q000378:metabolism / Q000503:physiopathology; D010147:Pain Measurement / Q000379:methods; D010148:Intractable Pain / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D049268:Positron-Emission Tomography; D020127:Recovery of Function / Q000502:physiology; D012701:Serotonin / Q000378:metabolism; D013788:Thalamus / Q000098:blood supply / Q000000981:diagnostic imaging / Q000502:physiology; D016896:Treatment Outcome
D012701:Serotonin